This brand name is authorized in Nigeria.
The drug DIPLOVAS contains one active pharmaceutical ingredient (API):
1
|
UNII
864V2Q084H - AMLODIPINE BESYLATE
|
|
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-5370 | Tablet | DIPLOVAS 5MG TABLETS TAB 5 mg 2X14 | 35 RNW-PP-147420 DIPLOVAS 5MG TABLETS AMLODIPINE AMLODIPINE BESILATE BP EQ. TO AMLODIPINE 5MG B4-5370 Drugs Imported Products 2X14 Prescription Only Medicine (POM) 1/21/2021 CHARTERHOUSE PHARMACEUTICS LIMITED, BLOCK C, NERDC ROAD, CENTRAL BUSINESS DISTRICT, ALAUSA, IKEJA LAGOS LAGOS 8134150172 charterhouseparmaceutics@gmail.com CIRON DRUGS AND PHARMACEUTICAL PVT. LTD, Plot No. 35 to 37 43 to 45, CFC-B Dewan Udyog Nagar, Aliyali, Palghar, Distr. Palghar-401 404, Maharashtra State, India, China | 28/09/2023 |
| B4-5410 | Tablet | DIPLOVAS 10MG TABLETS TAB 10 mg 2X14 | 36 RNW-PP-147438 DIPLOVAS 10MG TABLETS AMLODIPINE DIPLOVAS/AMLODIPINE TABLETS 10MG: Each uncoated tablet contains: Amlodipine Besilate BP Equivalent to Amlodipine (10MG) B4-5410 Drugs Imported Products 2x14 Prescription Only Medicine (POM) 1/21/2021 CHARTERHOUSE PHARMACEUTICS LIMITED, BLOCK C, NERDC ROAD, CENTRAL BUSINESS DISTRICT, ALAUSA, IKEJA LAGOS LAGOS 8134150172 charterhouseparmaceutics@gmail.com CIRON DRUGS AND PHARMACEUTICALS PVT.Ltd, Plot Nos 35-37 TO 43-45, CFC-B, Diwan Udyog Nagar, Aliyali, Palghar, Dist, Thane- 401 404, Maharashtra, INDIA., India | 28/09/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C08CA01 | Amlodipine | C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-5370, B4-5410 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.